RPG Life Sciences Limited (NSE:RPGLIFE)
2,277.40
-0.70 (-0.03%)
Jun 19, 2026, 3:30 PM IST
RPG Life Sciences Market Cap
RPG Life Sciences has a market cap or net worth of 37.67 billion as of June 18, 2026. Its market cap has increased by 4.41% in one year.
Market Cap
37.67B
Enterprise Value
35.11B
Revenue
7.08B
Ranking
n/a
PE Ratio
32.70
Stock Price
2,277.40
Market Cap Chart
Since June 10, 2008, RPG Life Sciences's market cap has increased from 645.16M to 37.67B, an increase of 5,738.22%. That is a compound annual growth rate of 25.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 37.67B | -1.93% |
| Dec 31, 2025 | 38.41B | 6.31% |
| Dec 31, 2024 | 36.13B | 63.53% |
| Dec 29, 2023 | 22.09B | 57.71% |
| Dec 30, 2022 | 14.01B | 37.00% |
| Dec 31, 2021 | 10.23B | 67.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 92.58B |
| Sun Pharma Advanced Research Company | 77.27B |
| Aarti Pharmalabs | 59.70B |
| Innova Captab | 53.39B |
| Orchid Pharma | 49.66B |
| Solara Active Pharma Sciences | 27.34B |
| Indoco Remedies | 21.42B |
| Beta Drugs | 20.09B |